Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Display:
?
Drug:  ascorbic acid
Find trials that include:  Any drugs shown
Results 1-6 of 6 for your search:
Start Over
Ascorbic Acid, Gemcitabine Hydrochloride, and Erlotinib Hydrochloride in Treating Patients With Metastatic Pancreatic Cancer
Status: Active
Phase: Phase II
Type: Treatment
Age: 18 to 75
Trial IDs: 11D.365, NCI-2012-00340, 2008-52(1), NCT01555489
High-Dose Ascorbic Acid in Treating Patients with Stage IIIB-IV Non-small Cell Lung Cancer
Status: Active
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: 201412760, NCI-2015-00709, NCT02420314
Docetaxel with or without Ascorbic Acid in Treating Patients with Metastatic Prostate Cancer
Status: Active
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: J15106, NCI-2015-01169, IRB00070691, NCT02516670
Gemcitabine Hydrochloride, Ascorbic Acid, and Radiation Therapy in Treating Patients with Pancreatic Cancer That Cannot Be Removed by Surgery
Status: Active
Phase: Phase I
Type: Treatment
Age: 18 and over
Trial IDs: 201310772, NCI-2014-00824, GAX-PAN-I, NCT01852890
Bevacizumab and Ascorbic Acid in Patients Treating with Recurrent High Grade Glioma
Status: Active
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 19 and over
Trial IDs: 769-15, NCI-2016-00239, 769-15-FB, NCT02833701
Ascorbic Acid and Combination Chemotherapy in Treating Patients with Locally Advanced or Recurrent Pancreatic Cancer That Cannot Be Removed by Surgery
Status: Not yet active
Phase: No phase specified
Type: Treatment
Age: 18 to 75
Trial IDs: 16D.347, NCI-2016-01319, NCT02896907
Start Over